STWX:SW:SW-SPDR® MSCI Europe Health Care UCITS ETF CHF (CHF)

ETF | Others |

Last Closing

USD 205.85

Change

-0.95 (-0.46)%

Market Cap

USD 0.74B

Volume

218.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHDIV:SW UBS ETF (CH) - MSCI Switzerlan..

+0.23 (+1.76%)

USD 1,244,681.59B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

-0.95 (-0.39%)

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.09 (+0.41%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.26 (+0.97%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+56.00 (+1.04%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+8.80 (+0.53%)

USD 134,034.86B
RGLDO:SW Raiffeisen ETF Solid Gold Ounc..

+19.50 (+0.88%)

USD 134,034.85B
SPICHA:SW UBS ETF (CH) – SPI® (CHF) A..

+0.47 (+0.63%)

USD 131,872.43B

ETFs Containing STWX:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.17% 50% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.17% 50% F 54% F
Trailing 12 Months  
Capital Gain 9.25% 35% F 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.25% 35% F 41% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.04% 56% F 57% F
Dividend Return 5.04% 56% F 57% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6.64% 61% D- 65% D
Risk Adjusted Return 75.84% 63% D 67% D+
Market Capitalization 0.74B 66% D+ 61% D-

Annual Financials (CHF)

Quarterly Financials (CHF)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike